h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
UMi028-A
Registration Summary
:
A
P
E
C
ASE9203
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
UMi028-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
UMi028-A (RRID:CVCL_A1MH)
Alternative name(s)
ASE9203
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
3rd June 2020
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
University of Miami - Miller School of Medicine (UM)
External Databases
Cellosaurus
CVCL_A1MH
Wikidata
Q102115077
General Information
Publications
Gosstola NC et al. Characterization of UMi028-A-1 stem cell line that contains a CRISPR/Cas9 induced hearing loss-associated variant (V60L (c.178G > T)) in the P2RX2 gene. Stem cell research. 2020 Dec;49:102017.
Lu L et al. Application of CRISPR/Cas9 in Alzheimer's Disease. Frontiers in neuroscience. 2021;15:803894.
Potjewyd FM et al. Exploration of Aberrant E3 Ligases Implicated in Alzheimer's Disease and Development of Chemical Tools to Modulate Their Function. Frontiers in cellular neuroscience. 2021;15:768655.
Laverde-Paz MJ et al. Derivation of stem cell line UMi028-A-2 containing a CRISPR/Cas9 induced Alzheimer's disease risk variant p.S1038C in the TTC3 gene. Stem cell research. 2021 Apr;52:102258.
Liu X et al. Generation and Genetic Correction of USH2A c.2299delG Mutation in Patient-Derived Induced Pluripotent Stem Cells. Genes. 2021 May 25;12(6).
Sen T et al. CRISPR and iPSCs: Recent Developments and Future Perspectives in Neurodegenerative Disease Modelling, Research, and Therapeutics. Neurotoxicity research. 2022 Oct;40(5):1597-1623.
Mollashahi B et al. Research and Therapeutic Approaches in Stem Cell Genome Editing by CRISPR Toolkit. Molecules (Basel, Switzerland). 2023 Feb 20;28(4).
Wong Poh Kuan et al. The Promises and Pitfalls of CRISPR-Mediated Base Editing in Stem Cells. The CRISPR Journal. 2023-06-01.
Cukier HN et al. An Alzheimer's disease risk variant in TTC3 modifies the actin cytoskeleton organization and the PI3K-Akt signaling pathway in iPSC-derived forebrain neurons. Neurobiology of aging. 2023 Nov;131:182-195.
Subclones
UMi028-A-1
UMi028-A-2
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.